secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeueHealth, Inc. (—)
CIK:        0001671284
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001104659-25-095898
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 2.01, 2.03, 3.01, 3.02, 3.03, 5.02, 5.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeueHealth taken private by NEA affiliate at $7.33/share; enterprise value ~$1.496B
--------------------------------------------------------------------------------

- Merger closed Oct 2, 2025; common stockholders (excluding rollover/excluded) receive $7.33/share cash.
- Enterprise value ~$1.496B; certain stockholders including NEA roll equity into private company.
- CEO Mike Mikan and executive team remain; 100% equity rolled over; board replaced with new directors.
- Company notified NYSE to delist; intends to file Form 15 to suspend SEC reporting obligations.
- Loan agreement amended: $25M tranche 2A funded; minimum cash covenant raised to $25M; total loan commitments remain $95M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671284/000110465925095898/0001104659-25-095898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671284/000110465925095898/tm2527826d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-095898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer